Please confirm that the title of the tutorial
for which you wish to receive VOICE Credit
is displayed in window below. If not correct,
please select the correct title.

Name:        
Address1: 
Address2: 
City/State/Zipcode:
Email Address:      
Voice #:                  
Work Phone #:       
Work Fax  #:           
Student (Nuclear Medicine)   Yes      No
Special Needs:      

TEST: PET Radiopharmaceuticals

1. What Does PET stand for?:

        Positive Effective Therapy

        Proton Emission Tomography

        Positron Effective Therapy

        None of the Above

2. Which ONE of the following isotopes can NOT be used for Coincidence Imaging?:

        Co-57

        C-11

        O-15

        N-13

3. Which ONE of the following series contains ONLY positron emitters?:

        Rb-82, F-18,Co-57

        N-13, F-18, Co-57

        C-11, N-13, Rb-82

        I-123, I-125, I-131

4. Which ONE of the following oncologic indications has NOT been approved by Medicare for reimbursement?:

        Testicular Carcinoma

        Ovarian Cancer

        Lymphoma

        Colorectal Cancer

5. What is the method of localization of FDG in malignant tumors?:

        Metabolic Trapping

        Receptor Binding

        Metabolic Interpolation

        Glucose Intolerance

6. What is the most commonly used PET Radiopharmaceutical worldwide?:

        F-18 FDG

        C-11 Labeled Co2

        N-13 Ammonia

        O-15 H2O

7. Which Statement is Correct?:

        FDG is the only F-18 compound ever synthesized for nuclear medicine usage.

        F-18 has synthesized several compounds for use in nuclear medicine.

        N-13 Ammonia has a better half life than F-18 for clinical nuclear medicine usage.

        Rb-82 has never been used for PET imaging.

8. The Half Life of F-18 is?:

        118 minutes

        18 minutes

        110 minutes

        2.04 minutes

9. For which of the following conditions does PET have great diagnostic value?: 

        Metastatic Disease

        Differentiating Necrosis From Tumor

        Primary Tumors

        All of the Above

10. Which is a correct statement about PET pharmaceuticals?:

        It must alter the process it is trying to image.

        It must avoid any metabolic interaction.

        It must ensure metabolic changes to the target organ.

        It must not alter the process it is trying to image.

To ensure a prompt processing of your registration,
please enter the security code below:

Security Code: 

Please enter security code:

BACK TO QUIZ CATALOG PAGE